The Pfizer Prize for Infectious Diseases Switzerland 2004
Awarded to Daiana Stolz
For her Work on the Development of a New Drug for the Treatment of Pneumonia
The Pfizer Prize for Infectious Diseases Switzerland 2004 has been awarded to Daiana Stolz, a 47-year-old physician and scientist at the University Hospital Basel. The prize, which is awarded annually to a young scientist who has made a significant contribution to the field of infectious diseases, is worth CHF 50,000.
Stolz's research focuses on the development of new drugs for the treatment of pneumonia, a leading cause of death worldwide. She has developed a new drug that is effective against a wide range of bacteria, including those that are resistant to antibiotics. The drug is currently in clinical trials, and if successful, it could have a major impact on the treatment of pneumonia.
Stolz is a highly accomplished scientist with a strong track record of research. She has published over 50 papers in peer-reviewed journals and has been awarded several prestigious grants. She is also a member of the Swiss Society of Infectious Diseases and the European Society of Clinical Microbiology and Infectious Diseases.
The Pfizer Prize for Infectious Diseases Switzerland is a prestigious award that recognizes the outstanding work of young scientists in the field of infectious diseases. Stolz is a deserving recipient of the prize, and her work has the potential to make a significant contribution to the global fight against infectious diseases.
Comments